Wearable ECG Recorder (YMHeart XY-12); Wearable ECG Recorder (YMHeart XY-1201); Wearable ECG Recorder (YMHeart XY-1202); Wearable ECG Recorder (YMHeart XY-1203); Wearable ECG Recorder (YMHeart XY-03); Wearable ECG Recorder (YMHeart XY-0301); Wearable ECG Recorder (YMHeart XY-0302); Wearable ECG Recorder (YMHeart XY-0303)
Shenzhen Xinyan Medical Technology Co.,ltd. · Decision date Sep 11, 2026
What did the FDA decide?
On September 11, 2026, FDA recorded a substantially equivalent (SESE) decision for K254119, a traditional 510(k) from Shenzhen Xinyan Medical Technology Co.,ltd. The submission covers the Wearable ECG Recorder under eight YMHeart model designations (XY-12, XY-1201, XY-1202, XY-1203, XY-03, XY-0301, XY-0302, XY-0303), classified as an ambulatory electrocardiograph without analysis under 21 CFR 870.2800, Class II, product codes MWJ and DRG, in the cardiovascular panel. SESE is a clearance to market, not a PMA approval.
The stated indication is to acquire, record and store continuous ECG data as directed by a clinician for patients aged 18 and older, for up to 7 days in hospital, clinic or home settings, with data transferred to PC software over USB. The summary describes a reusable recorder host with a single-use sensor and battery, plus Bluetooth for fit verification. The summary states clinical testing was not needed and cites non-clinical testing; the underlying test data, predicate comparison details and any limitations are not in the provided excerpts.
The public record does not include the full indications enclosure, the predicate's complete labeling, or the performance data supporting equivalence, so independent assessment of those points is not possible from this material.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254119
- Regulatory pathway
- 510(k) premarket notification
- Product code
- MWJ
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Electrocardiograph, Ambulatory (Without Analysis).
- Product code
- MWJ
- FDA device class
- 2
FDA decision timeline
K254119 received
Application receipt date recorded by FDA.
K254119 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MWJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
iCOR BeatK260383 | iCOR Medical, LLC | 510(k) clearance | Nov 2, 2026 | FDA |
Peerbridge COR MDx (Cor MDx)K253529 | Peerbridge Health, Inc. | 510(k) clearance | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Xinyan Medical Technology Co.,ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K254119
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
